JPMorgan Chase & Co. began coverage on shares of WUXI BIOLOGICS (CA (OTCMKTS:WXXWY) in a report issued on Thursday morning, The Fly reports. The brokerage issued an overweight rating on the stock.
WUXI BIOLOGICS (WXXWY) opened at $12.87 on Thursday. WUXI BIOLOGICS has a 12 month low of $10.55 and a 12 month high of $12.96.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Equities Focus and is the property of of Equities Focus. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.equitiesfocus.com/2018/01/08/wuxi-biologics-ca-wxxwy-coverage-initiated-by-analysts-at-jpmorgan-chase-co.html.
Receive News & Ratings for WUXI BIOLOGICS (CA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WUXI BIOLOGICS (CA and related companies with MarketBeat.com's FREE daily email newsletter.